Evidence map

ArticleBMC endocrine disorders2025

Targeting syndecan-2 inhibits papillary thyroid cancer invasiveness and de-differentiation.

Rui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41152817